Back/Acadia Healthcare's Rx to Go Earns Re-Accreditation for Excellence in Oncology Care
pharma·October 31, 2025·achc

Acadia Healthcare's Rx to Go Earns Re-Accreditation for Excellence in Oncology Care

ED
Editorial
Cashu Finance·3 min read
TL;DR
  • Rx to Go, an FCS pharmacy, achieved re-accreditation from ACHC, emphasizing excellence in oncology care until November 2028.
  • The accreditation highlights Rx to Go's commitment to patient safety and innovative practices in specialty pharmacy services.
  • Rx to Go's success sets a high standard for quality care in oncology, influencing the broader healthcare ecosystem.

Rx to Go Achieves Re-Accreditation, Highlighting Commitment to Oncology Care

Rx to Go, LLC, the in-house specialty pharmacy for Florida Cancer Specialists & Research Institute (FCS), has successfully secured re-accreditation from the Accreditation Commission for Health Care (ACHC) for its pharmacy services, with a distinguished focus on oncology. This important recognition, valid through November 2028, underscores Rx to Go’s unwavering dedication to excellence in operational practices, safety, and patient care. Paul Chadwick, FCS's Chief Value and Procurement Officer, emphasizes that this accreditation reflects the expertise and commitment of the pharmacy professionals dedicated to providing patients with effective therapies in a responsible manner.

The ACHC, a nonprofit organization established in 1986, plays a crucial role in enhancing the quality of healthcare services. Rx to Go's successful re-accreditation involves rigorous compliance with national standards, showcasing its commitment to high-quality care. This achievement not only confirms the pharmacy's adherence to these stringent benchmarks but also reinforces its pivotal role in advancing treatment quality and safety for oncology patients. According to Ryan Ciarrocchi, CEO of FCS, earning this accreditation with distinction exemplifies the organization’s continuous pursuit of excellence in oncology care, further solidifying Rx to Go's reputation as a leader in the specialty pharmacy sector.

The recognition by ACHC serves as a significant benchmark for pharmacy services, affirming Rx to Go's commitment to improving patient care through innovative practices and adherence to nationally recognized standards. This achievement highlights the integral role of the pharmacy program in delivering exceptional outcomes for patients battling cancer, showcasing the organization's mission to lead with integrity and elevate the standards of care in the field of oncology.

In related news, the emphasis on quality care in specialty pharmacy services is becoming increasingly vital as healthcare systems evolve to meet the complex needs of patients. Organizations like Rx to Go demonstrate that maintaining high standards of care not only benefits patients but also strengthens the overall healthcare ecosystem. The focus on re-accreditation reflects a broader industry trend towards enhancing safety, quality, and operational excellence across various healthcare services.

As the healthcare landscape continues to shift, Rx to Go's commitment to excellence in pharmacy services sets a standard that others may strive to emulate, providing a model for how specialized services can improve patient outcomes and ensure reliable access to essential therapies. The emphasis on continuous improvement and adherence to recognized standards is critical as the demand for high-quality cancer care remains a priority in the healthcare community.